Optimal genome profiling for re-biopsy of TKI resistant tumour

Date 08 October 2016
Event ESMO 2016 Congress
Session Definition and management of oligoprogression during treatment with TKI inhibitors
Topics Pathology/Molecular Biology
Non-Small Cell Lung Cancer
Basic Scientific Principles
Presenter Keith Kerr
Authors K. Kerr
  • Aberdeen Royal Infirmary, AB25 2ZN - Aberdeen/GB